# Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.

> **NCT06164639** · — · ENROLLING_BY_INVITATION · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 28 (estimated)

## Conditions studied

- ARDS, Human
- Aspiration Pneumonia

## Interventions

- **BEHAVIORAL:** aspiration
- **DIAGNOSTIC_TEST:** bronchial alveolar fluid
- **DEVICE:** EIT V/Q test
- **OTHER:** Nitric oxide inhalation

## Key facts

- **NCT ID:** NCT06164639
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-28
- **Primary completion:** 2025-11-28
- **Final completion:** 2026-11-28
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164639, "Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06164639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*